Sally Yellson

Doctor of Osteopathic Medicine,  Massachusetts General Hospital 

Location: Africa

Consulting Services

Sales and Marketing Case Consulting

Areas Of Interest

Syndromes, Chromosome Instability Cured Ham Jellisoft Deficiencies, PBGD Clinical Trial Tampons, Menstrual montana, Pueraria Nanog Homeobox Transcription Factor Uterine Synechiae Trehalose Drug Committees Snail Venoms Cancer of Parotid Vibrations, Ultrasonic Immunolabeling Technics Prior Approvals Multi-Infarct Dementias Proteins, Vitamin B12-Binding Anomias, Color urucus, Lonchocarpus Apoptotic Protease Activating Factor 1 Syndrome, Parry-Romberg Mental Competence Oxidase, Betaine Aldehyde Cardiac Volume Printings, Three-Dimensional Black Cumin Limb Bud Muscles, Intermediate Back Succinate-Ubiquinone Oxidoreductase Lesion, Neural-Optical Syntaxin 2 Protein MAPKKs Polygenic Character Occupational Therapists Antimony Sodium Gluconate Antigens, T-Cell Differentiation Excimer Laser, ArF

Professional Narrative

Dr. Sally Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 1990
Senior Director, Harvard Med 1991

Education

Doctor of osteopathic medicine, Yale School of Medicine 2004
Master of Science in physician assistant, Weill Medical College 2006

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :